EP PerMed Education Call 2025: The EP PerMed Guide to Personalised Medicine for Healthcare Professionals

The EP PerMed Education Call 2025 is a funding initiative aimed at enhancing the knowledge and skills of healthcare professionals (HCPs) in personalized medicine (PM). The program seeks to address the knowledge gaps in PM, which are seen as major obstacles to its effective integration into clinical practice. This opportunity allows consortiums of eligible organizations to develop educational content for HCPs, covered under a total budget of €300,000, with grants of up to €50,000 available for each project.

Eligible applicants include academic institutions, organizations in the clinical and public health sectors, private companies, and relevant stakeholders such as NGOs and medical societies. However, partners within the existing EP PerMed consortium and private individuals are excluded from participation. Each consortium must consist of at least two independent organizations from different EU Member States or Horizon Europe-associated countries, with a maximum of five members.

Proposals must focus on developing educational modules that will be delivered through an online platform, specifically targeting topics such as enhancing PM knowledge for general practitioners, exploring the impact of PM on oncology and cardiovascular diseases, interdisciplinary collaboration among HCPs, and improving communication skills with patients. The projects will follow a development stage where selected teams will create online course content intended to be completed within 12 months.

The application process is competitive, involving a single-stage submission along with an eligibility check, online pitching, and evaluations. Only proposals scoring at least 70 out of 100 will be eligible for funding. The success rate of the call is competitive, with the likelihood of selecting up to six projects based on the scoring and the number of applicants.

Funding is structured as a lump-sum grant, with 50% paid upfront and the remaining half after submission and approval of the final report. Importantly, there are no co-funding requirements imposed on applicants.

To apply, proposals need to be submitted before the deadline of September 9, 2025, with all applications required to be in English and properly formatted using the provided templates. Furthermore, all proposed modules must be relevant to a European audience and should not exceed the funding cap of €50,000, where costs associated with learning management systems and marketing are not covered.

Overall, this call presents a significant opportunity for healthcare organizations to contribute to the advancement of PM education, promoting better health outcomes through informed and trained HCPs. Interested applicants can find further information and guidelines through the EP PerMed website.

The EP PerMed Education Call 2025 is a funding opportunity aimed at supporting the development of educational content for healthcare professionals (HCPs) in the field of personalised medicine (PM). The call seeks to address the identified gaps in PM knowledge and skills among HCPs, which are considered a key barrier to the effective implementation of personalised medicine in clinical practice. The initiative aims to enhance the capacity of HCPs to integrate PM into their daily practice by equipping them with the necessary knowledge, skills, and competencies.

The scope of the call encompasses general and specialised education on PM and its implementation in clinical practice, interdisciplinary collaboration among HCPs, and effective communication between HCPs and patients. The selected projects will develop high-quality content that will be integrated into online modules/courses, collaboratively developed with the Digital Learning Team supporting EP PerMed. These modules/courses will be hosted and disseminated through the EP PerMed website and the eLearning platform designated by EP PerMed.

The modules/courses are intended to cater to the training needs of HCPs in PM implementation, including General Practitioners, Specialists, and Nurses. The content may include case studies demonstrating successful implementation of PM strategies in primary healthcare and selected disease areas, activities to foster interdisciplinary collaboration between HCPs for PM solutions, and activities to improve communication skills of HCPs with patients.

The call will select up to six modules covering one or more of the following topics:

1. Enhance PM knowledge:
Target audience: General Practitioners (GPs)
Description: Equip GPs with foundational knowledge of PM and its relevance in primary care.

2. Impact of PM in Oncology to improve patient care strategies:
Target audience: Specialists in Oncology / Haematology
Description: Highlight the impact and relevance of PM in oncology/haematology and CVD to improve patient care strategies.

3. Impact of PM in Cardiovascular Disease (CVD) to improve patient care strategies:
Target audience: Specialists in CVD
Description: Highlight the impact and relevance of PM in CVD to improve patient care strategies.

4. Interdisciplinary collaboration:
Target audience: All HCPs (GPs, Specialists, Nurses)
Description: Encourage collaboration across various medical disciplines and with patient associations to integrate PM approaches effectively.

5. Implementation of molecular diagnosis approaches in clinical practice:
Target audience: Specialists across disease areas
Description: Provide HCPs with a comprehensive understanding of genetic testing and molecular diagnostics and its application in PM, ultimately influencing its standard use in clinical practice.

6. Improve communication Skills of HCPs:
Target audience: All HCPs (GPs, Specialists, Nurses)
Description: Develop effective communication strategies for discussing PM options with patients, including explaining benefits, risks, and potential outcomes.

The total funding available for this call is 300,000 EUR. Selected projects will receive funding of up to 50,000 EUR per module, which can be used to cover eligible costs. The funding will be provided through lump sum contracts, with 50% pre-payment and the remaining 50% disbursed upon approval of the final activity report.

Key Dates and Timeline:
Opening of the Call for Proposals submission: 04 June 2025
Call information webinar: 18 June 2025, at 12.00 CEST
Online matchmaking period: 16 June 2025 to 01 September 2025
Q&A online session: 02 September 2025, at 12.00 CEST
Deadline for proposals submissions: 09 September 2025, at 16.00 CEST
Notification of eligibility check outcome and invite to online pitches: 17 September 2025
Online pitching sessions: 6-10 October 2025
Final Results notification: 29 October 2025

Eligibility Criteria:
To be eligible for funding, applications must meet the following criteria:
Proposals must be submitted via the application platform before the deadline on 9 September 2025 at 16:00 CEST.
Applicants must use the templates provided in the application platform to submit their proposal.
Proposals may be submitted by organisations registered in an EU Member State or a Horizon Europe-associated country.
Partners/Beneficiaries within the EP PerMed consortium and private persons are not eligible for this Call.
Applications must be written in English.
All modules must address a European audience.
Applications must request no more than 50,000 EUR (fifty thousand Euros) of funding including overheads.
Costs for a learning management system are not eligible for funding.
Costs for marketing and course promotion are not eligible for funding.
Projects must last no longer than 12 months.
The consortium must include a minimum of two eligible organisations, independent of each other, each established in different European Member States or Associated Countries.
All legal entities must be independent of each other.
The maximum number of project consortium members in applying consortia is five.
At least one non-academic organisation must be included in the consortium.
The consortium must be complete at the time of submission.
At least one project consortium member must have validated experience in designing lifelong learning (adult learning) education activities.
At least one project consortium member must have validated experience in the implementation of personalised medicine.

Eligible Applicants:
Proposals may be submitted by applicants belonging to one of the following categories:
Academia: research teams working at universities, universities of applied sciences, other higher education institutions, research and knowledge dissemination organisations or research institutes.
Clinical/public health sector: research teams working at hospitals, policlinics, medical practices, public health and/or other health care settings and health organisations.
Companies: private companies of all sizes; CME/CPD companies/agencies.
Other stakeholders: e.g. citizen organisations, medical societies, local communities, local/national NGOs, consumer organisations.

Evaluation Process and Criteria:
The selection process involves a single proposal submission through the EIT Health Smart Simple application platform. Each proposal will be evaluated by three external independent evaluators, and the final score will be the average of the three scores. Projects will be scored out of 100, and a minimum score of 70/100 is required for funding consideration. Projects will be ranked by evaluation score for each topic, and the top-ranked application will be selected for funding if more than one application scores 70/100 in a topic.

The evaluation criteria include:
Activity Excellence and Strategic Fit (Weight = 20%): Clarity and pertinence of the project’s objectives, and the extent to which the proposed work is ambitious and innovative. Soundness of the proposed approach, including the underlying concepts, models, assumptions, interdisciplinary approaches and fit with the module topics.
Impact and Sustainability (Weight = 40%): Credibility of the pathways and design approach to achieve the expected outcomes and impact of the module. Suitability and quality of the measures to maximise expected learning outcomes. Credibility of recommendations to EP PerMed for optimal dissemination.
Implementation and Feasibility (Weight = 40%): Quality and effectiveness of the work plan, assessment of risks, and appropriateness of the effort assigned to work packages, and the resources overall. Capacity and role of each participant in the consortium, and the extent to which the consortium brings together the necessary expertise.

Redress Procedure:
Applicants can appeal against the final award decision if they suspect a breach in the evaluation and selection procedures. Appeals must be submitted to EIT Health via email (appeals@eithealth.eu) within seven calendar days following notification of the application outcome.

Further Information:
For more information, visit https://www.eppermed.eu/educall2025 or contact calls_eppermed@eithealth.eu. When emailing, pre-fix the email subject with “EP PerMed_Edu” and your application code.

The EP PerMed Education Call 2025 is a funding opportunity designed to improve the knowledge and skills of healthcare professionals in personalised medicine. It aims to fund the development of online educational modules that will be hosted on the EP PerMed platform. Consortia of at least two eligible organizations from different European Member States or Associated Countries can apply for up to 50,000 EUR to create content on specific topics related to personalised medicine, such as enhancing PM knowledge for GPs, the impact of PM in oncology and cardiovascular disease, interdisciplinary collaboration, implementation of molecular diagnosis, and improving communication skills. The call emphasizes the importance of addressing a European audience and requires consortia to have experience in both lifelong learning and personalised medicine implementation. The evaluation process focuses on the excellence, impact, and feasibility of the proposed activities.

Eligible Applicant Types: The eligible applicant types for this opportunity include: Academia (research teams working at universities, universities of applied sciences, other higher education institutions, research and knowledge dissemination organisations or research institutes), Clinical/public health sector (research teams working at hospitals, policlinics, medical practices, public health and/or other health care settings and health organisations), Companies (private companies of all sizes; CME/CPD companies/ agencies), and Other stakeholders (e.g., citizen organisations, medical societies, local communities, local/national NGOs, consumer organisations). It is specified that other stakeholders should be in a position to provide useful knowledge and perspectives to the consortium. Partners/Beneficiaries within the EP PerMed consortium and private persons are not eligible for this Call.

Funding Type: The primary financial mechanism is a subgrant, provided through lump sum contracts. Selected projects will receive funding of up to 50,000 EUR per project. The funding will be provided through lump sum contracts, with 50% pre-payment and the remaining 50% disbursed upon approval of the final activity report.

Consortium Requirement: A consortium of multiple applicants is required. The consortium must include a minimum of two eligible organizations, independent of each other, each established in different European Member States or Associated Countries. The maximum number of project consortium members in applying consortia is five. The consortium must be complete at the time of submission.

Beneficiary Scope (Geographic Eligibility): Proposals may be submitted by organizations registered in an EU Member State or a Horizon Europe-associated country. All modules must address a European audience.

Target Sector: The program targets the health sector, specifically focusing on personalised medicine (PM) and the development of educational content for healthcare professionals (HCPs) in this field. The call aims to enhance the capacity of HCPs to integrate PM into their daily practice. The specific topics covered include enhancing PM knowledge for general practitioners, the impact of PM in oncology and cardiovascular disease, interdisciplinary collaboration, implementation of molecular diagnosis approaches, and improving communication skills of HCPs.

Mentioned Countries: The opportunity is open to organizations registered in an EU Member State or a Horizon Europe-associated country.

Project Stage: The project stage is development. The call focuses on the provision and development of educational content. Selected projects will develop course content for a four-week online course.

Funding Amount: The funding amount is up to 50,000 EUR per project. The total funding available is 300,000 EUR.

Application Type: The application type is an open call with a single proposal submission.

Nature of Support: Beneficiaries will receive money in the form of a subgrant.

Application Stages: The application process involves several stages: Match (consortium formation), Apply (proposal submission), Eligibility check, Online pitching, Funding Decision, Design of modules, and Final Report.

Success Rates: The success rate is not explicitly stated, but projects need to score at least 70/100 to be considered for funding. Up to the six top-ranked projects will be selected.

Co-funding Requirement: Co-funding from the applicant or other parties is not explicitly mentioned as a requirement.

Summary:

The EP PerMed Education Call 2025 is a funding opportunity aimed at enhancing the knowledge and skills of healthcare professionals (HCPs) in the field of personalised medicine (PM). The call seeks to fund consortia that will develop high-quality educational content, which will be integrated into online modules and courses hosted on the EP PerMed website and eLearning platform. The goal is to bridge the gap in PM knowledge among HCPs and facilitate the implementation of PM in clinical practice.

The call covers six key topics: enhancing PM knowledge for general practitioners, the impact of PM in oncology, the impact of PM in cardiovascular disease, interdisciplinary collaboration among HCPs, implementation of molecular diagnosis approaches, and improving communication skills of HCPs. Consortia must consist of at least two eligible organizations from different EU Member States or Horizon Europe-associated countries, with a maximum of five members. Eligible organizations include academic institutions, clinical/public health sector entities, companies, and other relevant stakeholders.

The application process involves several stages, including consortium formation, proposal submission, eligibility check, online pitching, and module design. Selected projects will receive up to 50,000 EUR in funding, disbursed in two installments, and will have 12 months to develop the course content. The evaluation criteria include activity excellence, strategic fit, impact, sustainability, implementation, and feasibility. This call represents a significant effort to promote personalised medicine by equipping healthcare professionals with the necessary knowledge and skills through targeted educational initiatives.